VIDEO: OncoSec Medical, Inc. (ONCS)

OncoSec Medical Incorporated, a biotechnology company, designs, develops, and commercializes gene therapies, and therapeutics and proprietary medical approaches to stimulate and guide an anti-tumor immune response for the treatment of cancer in the United States. Its lead program, ImmunoPulse IL-12, is in Phase II development for various indications, including metastatic melanoma, squamous cell carcinoma of the head and neck, and triple-negative breast cancer. ImmunoPulse is an electroporation delivery device used in combination with the company’s therapeutic product candidates, including DNA plasmids that encode for immunologically active agents, and to deliver the therapeutic directly into the tumor and promote an inflammatory response against the cancer.


BLOG COMMENTS POWERED BY DISQUS

Get the Latest Videos

Small Cap Movers

Comstock Resources, Inc. Common

NYQ : CRK - 05 Feb, 11:47am
1.385
+0.105 (+8.203%) After Hours:
Open 1.220 Mktcap 66.09M
High 1.510 52wk Hight 6.840
Low 1.200 52wk Low 0.970
Vol 975467 Avg Vol 1.21M
Eps -4.600 P/e
Currency: USD

Argos Therapeutics, Inc.

NGM : ARGS - 05 Feb, 11:46am
3.03
-0.02 (-0.66%) After Hours:
Open 3.07 Mktcap 62.83M
High 3.15 52wk Hight 9.64
Low 3.00 52wk Low 1.61
Vol 25879 Avg Vol 106258
Eps -3.58 P/e
Currency: USD

Amyris, Inc.

NMS : AMRS - 05 Feb, 11:44am
1.45
+0.00 (+0.00%) After Hours:
Open 1.46 Mktcap 278.65M
High 1.49 52wk Hight 3.11
Low 1.44 52wk Low 1.13
Vol 6767 Avg Vol 156437
Eps -1.70 P/e
Currency: USD

Alliance Holdings GP, L.P.

NMS : AHGP - 05 Feb, 11:47am
18.09
-0.02 (-0.11%) After Hours:
Open 18.01 Mktcap 1.08B
High 18.37 52wk Hight 57.37
Low 17.45 52wk Low 12.43
Vol 48565 Avg Vol 169381
Eps 3.11 P/e 5.12
Currency: USD
×

Sign Up For Our Newsletter